Acadia Healthcare Co. (ACHC) Issues Q3 Earnings Guidance
Acadia Healthcare Co. (NASDAQ:ACHC) issued an update on its third quarter earnings guidance on Tuesday morning. The company provided EPS guidance of ~$0.58 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.66. The company issued revenue guidance of ~$735 million, compared to the consensus revenue estimate of $744.43 million.
Acadia Healthcare Co. (NASDAQ:ACHC) traded up 4.03% on Tuesday, reaching $45.19. 1,267,467 shares of the company’s stock were exchanged. Acadia Healthcare Co. has a one year low of $42.47 and a one year high of $74.77. The firm has a 50 day moving average price of $49.16 and a 200 day moving average price of $54.58. The firm has a market cap of $3.95 billion, a PE ratio of 24.14 and a beta of 0.86.
Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Friday, July 29th. The company reported $0.73 earnings per share for the quarter, meeting the consensus estimate of $0.73. The company earned $756.50 million during the quarter, compared to the consensus estimate of $752.57 million. Acadia Healthcare had a return on equity of 9.35% and a net margin of 6.44%. Acadia Healthcare’s revenue was up 66.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.57 EPS. On average, equities analysts anticipate that Acadia Healthcare Co. will post $2.63 earnings per share for the current year.
Several equities analysts have weighed in on ACHC shares. Jefferies Group reaffirmed a buy rating and issued a $85.00 target price on shares of Acadia Healthcare in a research report on Monday, June 27th. Zacks Investment Research downgraded Acadia Healthcare from a hold rating to a sell rating in a research report on Monday, July 11th. Leerink Swann reaffirmed an outperform rating and issued a $90.00 target price on shares of Acadia Healthcare in a research report on Friday, July 15th. Royal Bank Of Canada dropped their target price on Acadia Healthcare from $86.00 to $78.00 and set an outperform rating for the company in a research report on Monday, August 1st. Finally, RBC Capital Markets reaffirmed an outperform rating and issued a $78.00 target price (down from $86.00) on shares of Acadia Healthcare in a research report on Monday, August 1st. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The stock currently has an average rating of Buy and an average target price of $77.21.
In other Acadia Healthcare news, COO Ronald Morgan Fincher sold 8,800 shares of the business’s stock in a transaction that occurred on Monday, August 8th. The stock was sold at an average price of $52.56, for a total value of $462,528.00. Following the completion of the sale, the chief operating officer now owns 120,780 shares in the company, valued at $6,348,196.80. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, major shareholder Waud Capital Partners Iii, L.L sold 457,443 shares of the business’s stock in a transaction that occurred on Friday, September 16th. The shares were sold at an average price of $48.39, for a total value of $22,135,666.77. The disclosure for this sale can be found here. 17.20% of the stock is owned by corporate insiders.
A number of large investors have recently modified their holdings of the stock. BlackRock Institutional Trust Company N.A. boosted its stake in shares of Acadia Healthcare by 10.1% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 1,824,171 shares of the company’s stock worth $101,059,000 after buying an additional 166,706 shares in the last quarter. American Century Companies Inc. purchased a new stake in shares of Acadia Healthcare during the second quarter worth $56,657,000. State Street Corp boosted its stake in shares of Acadia Healthcare by 9.5% in the second quarter. State Street Corp now owns 975,338 shares of the company’s stock worth $54,038,000 after buying an additional 84,531 shares in the last quarter. BlackRock Fund Advisors boosted its stake in shares of Acadia Healthcare by 16.9% in the second quarter. BlackRock Fund Advisors now owns 908,476 shares of the company’s stock worth $50,330,000 after buying an additional 131,667 shares in the last quarter. Finally, Baird Financial Group Inc. boosted its stake in shares of Acadia Healthcare by 5.2% in the second quarter. Baird Financial Group Inc. now owns 543,968 shares of the company’s stock worth $30,133,000 after buying an additional 26,957 shares in the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.
Receive News & Stock Ratings for Acadia Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Co. and related stocks with our FREE daily email newsletter.